She created Addyi, the first FDA-approved drug for women with low libidos, dubbed by the media as ‘the female Viagra’, and sold the company that created it — Sprout Pharmaceuticals — for $1 BILLION. And then last year, she successfully sued to get it BACK. Why? And then what happened?
I had to get Cindy Eckert (formerly Whitehead) back on the show, not only to explain what’s going on with her company, but also update us on her unabashed mission to help make more women ‘really f—ing rich’.
She created Addyi, the first FDA-approved drug for women with low libidos, dubbed by the media as “the female Viagra”, and sold the company that created it —Sprout Pharmaceuticals — for $1 BILLION. And now, Cindy Whitehead isn’t slowing down. She’s created the Pink Ceiling… a venture to help more women focused businesses get the funding they need to skyrocket like she did.
A fitting name given Cindy’s signature pink outfits and matching lipstick — the new company is a cross between a VC firm, a ‘pinkubator’ and a consulting enterprise. Her mission is to mentor, invest in, launch.
